LBF20207PG43: Difference between revisions

No edit summary
No edit summary
Line 7: Line 7:
|LipidMaps=-
|LipidMaps=-
|SysName=9-oxo-11alpha,15S-dihydroxy- (8beta) -prosta-5Z,13E-dien-1-oic acid
|SysName=9-oxo-11alpha,15S-dihydroxy- (8beta) -prosta-5Z,13E-dien-1-oic acid
|Common Name=&&8-iso Prostaglandin E_2&&9-oxo-11alpha,15S-dihydroxy- (8beta) -prosta-5Z,13E-dien-1-oic acid&&
|Common Name=&&8-iso Prostaglandin E_2&&
|Source=
|Source=
|Chemical Synthesis=
|Chemical Synthesis=

Revision as of 21:00, 14 April 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



8-iso Prostaglandin E2
LBF20207PG43.png
Structural Information
9-oxo-11α,15S-dihydroxy- (8β) -prosta-5Z,13E-dien-1-oic acid
  • 8-iso Prostaglandin E2
Formula C20H32O5
Exact Mass 352.224974134
Average Mass 352.46508
SMILES C(CC[C@H](O)C=C[C@H]([C@@H]1CC=CCCCC(O)=O)[C@@H](CC1=O)O)CC
Physicochemical Information
8-iso PGE2 inhibits U-46619 or I-BOP-induced platelet aggregation with IC50 values of 0.5 and 5 mu M. Longmire_AW et al. 8-iso PGE2 is also reported to decrease 80% of the GFR and renal plasma flow without affecting blood pressure in infusing into the renal artery of rats. Pace-Asciak_C
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20207PG43 See above. Pace-Asciak_C 1976